Inventiva S.A. (IVA) stock
IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF
$3.22−0.10 (-3.01%)
Close on Nov 17, 2026Market cap $622.22MP/E –Yield –
Inventiva total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Inventiva's total debt was €35.14M at Jun 30, 2023. For fiscal 2022 it was €34.51M, up 241.1% from the year before. The highest annual figure on record is €34.51M in fiscal 2022.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | €34.51M | +241.1% |
| FY2021 | Dec 31, 2021 | €10.12M | +0.6% |
| FY2020 | Dec 31, 2020 | €10.06M | +8643.5% |
| FY2019 | Dec 31, 2019 | €115.00K | -48.9% |
| FY2018 | Dec 31, 2018 | €225.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2023 | Jun 30, 2023 | €35.14M | +30452.2% |
| Q4 FY2022 | Dec 31, 2022 | €34.51M | +15239.6% |
| Q4 FY2021 | Dec 31, 2021 | €10.12M | – |
| Q4 FY2020 | Dec 31, 2020 | €10.06M | – |
| Q4 FY2019 | Dec 31, 2019 | €115.00K | – |
| Q4 FY2018 | Dec 31, 2018 | €225.00K | – |
See a number that looks wrong?